Putting Science to Work

Archives / 2018 / January

  • /Media/Default/images/infd.jpg
    Focus on growth, investments; capacity in Biologics a growth driver: Syngene Intl

    Money Control-24/01/2018. With a focus on future business growth, the company has done lot of investments – building new infrastructure and capabilities and they are now ready, said Hunt...

    .

  • We are in the process of implementing a $200 million growth capex plan to expand capacity and extend capabilities

    Globally, we anticipate to see a healthy demand for high quality scientific services, not just in the pharma and biotechnology industries but also in other research focused industries...

    .

Discovery Chemistry Discovery Biology Safety Assessment Large Molecule Development Chemical Development Formulation Development Stability Studies Polymer Research Integrated Discovery & Development Clinical Development Services Bioinfomatics Antibody Drug Conjugates Oligonucleotide Synthesis Contact Us

This site is best viewed in Firefox (29+), Chrome (35+), or Microsoft Internet Explorer (9+)

Social Widget